MRg-NIRS Imaging System Breast Cancer Trial
Start Date
11/25/2024
Completion Date
7/1/2034
Summary
This trial is a study of 20 women with breast cancer to evaluate the addition of MR-guided (MRg) near-infrared spectroscopy (NIRS) with and without contrast, as part of a program to improve clinical management of women receiving breast magnetic resonance imaging (MRI).
Detailed Description
This trial is designed to determine if the MRg-NIRS system will contribute significantly to improved clinical management of women receiving breast magnetic resonance imaging (MRI) by achieving diagnostic performance comparable to or better than dynamic contrast-enhanced (DCE) breast MRI alone. The purpose of this clinical trial is to evaluate the addition of MRg-NIRS with and without contrast in 20 women with breast cancer. The women enrolled in the trial will be those who have a newly diagnosed breast cancer.
Eligibility Criteria
Age Range: 18 years to 83 years
Interventions
MRg-NIRS
Conditions
Locations
Dartmouth-Hitchcock Medical Center
Lebanon, New Hampshire 03756
United States